CASP3 and glioblastoma: Prior studies have reported that treatment with zerumbone suppressed FOXO1 and Akt phosphorylation due to inactivation of IKKα while activating caspase-3 protein and PARP, which resulted in decreased cell viability, and induction of apoptosis in GBM cells [62].